Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.
IPO Year: 2014
Exchange: NASDAQ
Website: recrogainesville.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
10/12/2021 | Outperform | William Blair |